The stock of MedReleaf Corp. has recently outperformed those of other top marijuana stock players in Canada, and there could be further price gains going forward after the recently listed cannabis firm has found its footing and stopped the earlier quarterly revenue declines.
Tag Archives: IPO
Why More Medical Marijuana IPOs Are Coming
Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price.
Zelda Provides CannPal Priority Share Offer Clarification Announcement
Further to the ASX announcement dated 29 August 2017 title ‘Priority Share Offer for CannPal Animal Therapeutics Ltd IPO Shares’, the Board of Zelda Therapeutics Ltd wishes to clarify the Priority Offer Record Date.
Zelda Announces Priority Share Offer for CannPal Animal Therapeutics IPO Shares
The Board of Zelda Therapeutics Ltd is pleased to announce that its shareholders are invited to participate as a priority applicant in the prospectus capital raising of CannPal Animal Therapeutics Limited (CannPal) lodged with the ASIC.
Cal Can Biz Expo Interview: MJIC’s Sturges Karban
In this Cal Can Biz Expo interview, watch Kristen Fox, Editor-in-Chief of MJINews.com and Marijuana Industry News magazine, interview Sturges Karban, CEO of MJIC.
Better Know a Marijuana Stock: MedReleaf Corp.
MedReleaf is one of less than four dozen licensed producers and retailers of medical cannabis products in Canada. The company was founded just four years ago, and it focuses on supplying dried cannabis, cannabis oils, and cannabis oil capsules to qualified medical patients in Canada.
Should Investors Consider Canopy Growth Corp. at These Levels?
The industry and the Canopy Growth Corp. were going to be the next big thing for investors, but things have cooled down gradually over the past few months.
This Massive Marijuana Stock IPO Imploded on Its First Day of Trading
In late May, MedReleaf priced its public offering at just over $7 per share. The marijuana stock IPO raised a whopping $75 million. Unfortunately, things didn’t work out as planned for pot investors or MedReleaf.
MedMen Opportunity Fund Closes Below $100 Million Target
On June 12, 2017, the MedMen Opportunity Fund, a California-based private equity fund focused on the legal marijuana industry, filed Form D with the United States Securities and Exchange Commission, indicating that it had raised approximately $60 million of its $100 million offering.
Could MedReleaf Corp. Reignite Interest in the Canadian Marijuana Scene?
MedReleaf Corp. is the latest cannabis stock to hit the TSX. Could they be the spark to reignite the second wave of the green rush?
Say Hello to the Largest North American Marijuana Stock IPO
In April, investors were privy to the very first marijuana stock ETF, which debuted on the Toronto Stock Exchange with slightly more than a dozen holdings. This represented the very first time a basket fund was created for investors to easily diversify their pot-stock holdings. And last week, investors witnessed another marijuana first: the largest North American marijuana stock IPO of all-time.
Marijuana Boom Gives Real Estate a Big High
U.S. real estate values are blazing, at least that is in the parts of the country where the sale of marijuana is now legal.
Unique Marijuana REIT Has IPO
Innovative Industrial Properties, Inc. (IIPR) is one of the latest and most notable companies focusing on marijuana to hit the markets, and the company had a fairly quiet IPO on Thursday, December 1.
Investors Hoping to Ride High on Trailblazing Marijuana Company
With several states passing measures to legalize marijuana in 2016, the cannabis business looks poised to finally to take off. But for investors, there remains a quandary: How do you find a way to get in on the ground floor of this new growth industry?
David Friedman Steps Down From MJIC, Inc.
LAKE FOREST, California, Sept. 15, 2016 — David Friedman resigned as CEO, and CFO of MJIC, Inc. (“Company”) as well as all officer and director positions held in the operating subsidiaries of the Company effective immediately. Randy Shipley shall remain the president of the Company.
24 Days Until First-Ever CannaPitch for Reg A+ Cannabis Companies
At the California Cannabis Business Expo in San Francisco this March, you can experience the legal cannabis industry’s first pitch event to focus on the hottest and fastest growing companies in cannabis as they begin their journey towards the ultimate prize.
3 Critical Benefits of Regulation A+ for Potential Issuers
While financing a regular startup is challenging, financing a cannabis-related startup is even more difficult. Regulation A+ could be a game changer for the legal cannabis industry by letting everyday cannabis consumers financially support the companies they love.
Planning Ahead for the Changing Times in Cannabis Public Markets
With the exception of the late-2013 to early-2014 bubble, from which fortunes were made, there has been little sustained progress in producing a truly public company sector Version 2.0. No doubt companies like Massroots (OTCQB: MSRT) have set the bar higher.
Zynerba: The Need for Speculative Fortitude
Zynerba presented the status of its research program at BIO Investor Forum. This is a 14-year-old annual biotech gathering, with roughly 600 attendees from 21 countries, and the presentation, in San Francisco, looked likely to be a big event in this company’s development.
Medicine Man Technologies Files Pre-IPO Documents with SEC
Ownership in the Medicine Man Denver stores—there are two now, one near the airport in Denver and one in Aurora—is not actually what is being pitched to investors in the S-1 from Medicine Man Technologies. The business of Medicine Man Technologies is actually consulting, but its model and outlook are inexorably tied to the highly successful cultivator and retailer you may have seen on MSNBC’s “Pot Barons” TV series.
Zynerba IPO a Big $275 Million Entry for Cannabinoids
It has been a bit of a dry spell for decent IPOs in the cannabis space. But the rains have come down with the initial public offering of Devon, Pennsylvania-based Zynerba Pharmaceuticals (NASDAQ: ZYNE).
Cannabis Company Fights Silicon Valley Shade
MassRoots (OTC.BB:MSRT) has been called the Facebook for pot smokers, but this online social website for the cannabis community is fighting cannabias.
On Private Vs. Public Companies, Unicorns and Cannabis
Would you like to invest in Uber? Or how about Airbnb? Well it turns out that you can’t. If you’re a regular Joe or Jane investor, there are no shares to buy for either company, or for companies like Pinterest and SpaceX.
Thursday MassRoots Kicks Off
The cannabis sector welcomed the successful introduction of MassRoots (OTCQB: MSRT), with shares traded comfortably above $1 with great volume.
Fascinating Case Study Begins April 9 as MassRoots Goes Public
MassRoots, which will begin trading on or around April 9, 2015, under the ticker MSRT, is set to be the first public cannabis company with a revenue model and a customer acquisition strategy built entirely around social media platforms.
Monday Making History
One of the best parts of being a cannabis investor is being able to witness history in the making on a daily basis. This time it is the announcement of the first cannabis tech IPO with MassRoots (OTC Pink: MSRT) preparing to come online this month.
The First Weed Tech IPO
This week, Mass Roots—a sort-of Facebook for weed lovers—will be one of the first canna-businesses to go public.
A Look Inside the S-1s of Upcoming Public Offerings
There are many early-stage companies with an eye on cannabis that are entering the publicly-traded space these days. We wanted to give you a brief overview of some of the companies that are likely to offer public securities for the first time in 2015.
Terra Tech Shaping the Future?
Terra Tech Corp. is not the only marijuana business with publicly traded stock, but it may be the only grower.